Literature DB >> 30613623

Non-invasive assessment of tumor PD-L1 status with circulating tumor cells.

Bryan C Ulrich1, Nicolas Guibert2.   

Abstract

Entities:  

Year:  2018        PMID： 30613623      PMCID： PMC6291604          DOI： 10.21037/atm.2018.10.09

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  5 in total

1.  PD-L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study.

Authors:  Muhammad A Khattak; Anna Reid; James Freeman; Michelle Pereira; Ashleigh McEvoy; Johnny Lo; Markus H Frank; Tarek Meniawy; Ali Didan; Isaac Spencer; Benhur Amanuel; Michael Millward; Melanie Ziman; Elin Gray
Journal:  Oncologist       Date:  2019-12-05

2.  Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer.

Authors:  Rika Noji; Kohki Tohyama; Takuma Kugimoto; Takeshi Kuroshima; Hideaki Hirai; Hirofumi Tomioka; Yasuyuki Michi; Akihisa Tasaki; Kazuchika Ohno; Yosuke Ariizumi; Iichiroh Onishi; Mitsukuni Suenaga; Takehiko Mori; Ryuichi Okamoto; Ryoichi Yoshimura; Masahiko Miura; Takahiro Asakage; Satoshi Miyake; Sadakatsu Ikeda; Hiroyuki Harada; Yoshihito Kano
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

3.  Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.

Authors:  Diego Signorelli; Patrizia Ghidotti; Claudia Proto; Marta Brambilla; Alessandro De Toma; Roberto Ferrara; Giulia Galli; Monica Ganzinelli; Giuseppe Lorusso; Arsela Prelaj; Mario Occhipinti; Giuseppe Viscardi; Valentina Capizzuto; Francesca Pontis; Ilaria Petraroia; Anna Maria Ferretti; Mario Paolo Colombo; Valter Torri; Gabriella Sozzi; Marina Chiara Garassino; Elena Jachetti; Orazio Fortunato
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

Review 4.  Extracellular Vesicles as Biomarkers in Cancer Immunotherapy.

Authors:  Matthen Mathew; Mariam Zade; Nadia Mezghani; Romil Patel; Yu Wang; Fatemeh Momen-Heravi
Journal:  Cancers (Basel)       Date:  2020-09-30       Impact factor: 6.639

Review 5.  A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancer.

Authors:  Jeong Uk Lim; Hye Seon Kang
Journal:  Ann Transl Med       Date:  2021-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.